Scorpius BioManufacturing is an integrated contract research, and contract development and manufacturing organization (CDMO) focused on mammalian and microbial large molecule biologics. We will offer commercial-scale biomanufacturing in the coming years from our newly announced site in Manhattan, Kansas. We currently provide a broad array of clinical-scale biomanufacturing, analytical and R&D services to pharmaceutical and biotech companies from our San Antonio, Texas facilities. Scorpius is proud to focus on offering services using American equipment, reagents, and materials.
Clinical-Scale Biomanufacturing Facility
Scorpius completed construction of our new clinical scale biologics manufacturing facility in San Antonio, Texas in 2022, which is fully operational.